Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Position Raised by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,012,938 shares of the medical equipment provider’s stock after purchasing an additional 6,847 shares during the period. Charles Schwab Investment Management Inc. owned 0.57% of Intuitive Surgical worth $688,304,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of ISRG. HHM Wealth Advisors LLC grew its holdings in shares of Intuitive Surgical by 1,314.3% during the 1st quarter. HHM Wealth Advisors LLC now owns 99 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 92 shares in the last quarter. Solstein Capital LLC acquired a new position in Intuitive Surgical in the 2nd quarter worth about $25,000. RFP Financial Group LLC raised its stake in shares of Intuitive Surgical by 166.7% during the 2nd quarter. RFP Financial Group LLC now owns 80 shares of the medical equipment provider’s stock worth $27,000 after purchasing an additional 50 shares in the last quarter. Marquette Asset Management LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter valued at approximately $28,000. Finally, Barrett & Company Inc. acquired a new position in Intuitive Surgical in the first quarter worth approximately $30,000. Institutional investors and hedge funds own 82.91% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on ISRG shares. Truist Financial increased their price target on shares of Intuitive Surgical from $347.00 to $400.00 in a research note on Wednesday, July 19th. StockNews.com lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Friday, October 20th. Morgan Stanley decreased their target price on Intuitive Surgical from $330.00 to $300.00 and set an “equal weight” rating for the company in a research report on Monday, October 23rd. SVB Leerink initiated coverage on shares of Intuitive Surgical in a research note on Monday, October 16th. They issued an “outperform” rating and a $342.00 price objective for the company. Finally, Barclays lifted their target price on shares of Intuitive Surgical from $314.00 to $385.00 and gave the stock an “overweight” rating in a report on Monday, July 24th. Five equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $342.20.

Insider Activity

In related news, Director Amy L. Ladd sold 500 shares of the stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $305.68, for a total transaction of $152,840.00. Following the sale, the director now directly owns 702 shares in the company, valued at approximately $214,587.36. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, EVP Robert Desantis sold 1,110 shares of the stock in a transaction that occurred on Tuesday, October 24th. The shares were sold at an average price of $273.49, for a total transaction of $303,573.90. Following the sale, the executive vice president now directly owns 7,259 shares of the company’s stock, valued at $1,985,263.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Amy L. Ladd sold 500 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $305.68, for a total transaction of $152,840.00. Following the completion of the transaction, the director now owns 702 shares of the company’s stock, valued at approximately $214,587.36. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 36,822 shares of company stock worth $9,759,729. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $293.22 on Thursday. The business’s fifty day moving average price is $283.98 and its two-hundred day moving average price is $305.08. Intuitive Surgical, Inc. has a fifty-two week low of $222.65 and a fifty-two week high of $358.07. The stock has a market capitalization of $103.23 billion, a price-to-earnings ratio of 68.99, a price-to-earnings-growth ratio of 4.67 and a beta of 1.31.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 19th. The medical equipment provider reported $1.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.06. The business had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.77 billion. Intuitive Surgical had a net margin of 22.14% and a return on equity of 12.91%. The firm’s revenue for the quarter was up 12.0% on a year-over-year basis. During the same quarter last year, the company posted $0.90 EPS. Research analysts expect that Intuitive Surgical, Inc. will post 4.54 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.